LSTA logo

Lisata Therapeutics (LSTA) Operating Profit

Annual Operating Profit

-$25.71 M
+$31.89 M+55.37%

December 31, 2023


Summary


Performance

LSTA Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAprofitabilitymetrics:

Quarterly Operating Profit

-$5.34 M
+$187.00 K+3.39%

September 30, 2024


Summary


Performance

LSTA Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAprofitabilitymetrics:

TTM Operating Profit

-$23.48 M
+$628.00 K+2.60%

September 30, 2024


Summary


Performance

LSTA TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

LSTA Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.4%+11.4%+8.7%
3 y3 years-34.3%+11.4%+8.7%
5 y5 years-51.3%+11.4%+8.7%

LSTA Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+55.4%at high+85.8%at high+59.5%
5 y5-year-34.3%+55.4%-31.5%+85.8%-26.9%+59.5%
alltimeall time<-9999.0%+55.5%-4220.6%+85.8%-8627.2%+64.5%

Lisata Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.34 M(-3.4%)
-$23.48 M(-2.6%)
Jun 2024
-
-$5.52 M(-16.3%)
-$24.11 M(-5.3%)
Mar 2024
-
-$6.60 M(+9.6%)
-$25.46 M(-0.9%)
Dec 2023
-$25.71 M(-55.4%)
-$6.03 M(+1.0%)
-$25.71 M(-2.0%)
Sep 2023
-
-$5.96 M(-13.3%)
-$26.22 M(-54.8%)
Jun 2023
-
-$6.88 M(+0.5%)
-$57.98 M(+0.3%)
Mar 2023
-
-$6.84 M(+4.6%)
-$57.82 M(+0.4%)
Dec 2022
-$57.60 M(+98.3%)
-$6.54 M(-82.7%)
-$57.60 M(-0.5%)
Sep 2022
-
-$37.72 M(+461.3%)
-$57.91 M(+113.2%)
Jun 2022
-
-$6.72 M(+1.5%)
-$27.16 M(-1.5%)
Mar 2022
-
-$6.62 M(-3.3%)
-$27.58 M(-5.0%)
Dec 2021
-$29.05 M(+51.7%)
-
-
Dec 2021
-
-$6.85 M(-1.7%)
-$29.05 M(+5.1%)
Sep 2021
-
-$6.97 M(-2.5%)
-$27.65 M(+6.2%)
Jun 2021
-
-$7.15 M(-11.6%)
-$26.03 M(+12.3%)
Mar 2021
-
-$8.09 M(+48.5%)
-$23.17 M(+21.0%)
Dec 2020
-$19.14 M(-4.7%)
-$5.45 M(+1.8%)
-$19.14 M(+1.9%)
Sep 2020
-
-$5.35 M(+24.7%)
-$18.78 M(+1.5%)
Jun 2020
-
-$4.29 M(+5.8%)
-$18.50 M(-5.4%)
Mar 2020
-
-$4.06 M(-20.2%)
-$19.56 M(-2.7%)
Dec 2019
-$20.09 M(+18.3%)
-$5.08 M(+0.2%)
-$20.09 M(+6.8%)
Sep 2019
-
-$5.07 M(-5.1%)
-$18.81 M(+7.5%)
Jun 2019
-
-$5.35 M(+16.4%)
-$17.50 M(+6.6%)
Mar 2019
-
-$4.59 M(+21.0%)
-$16.42 M(-3.3%)
Dec 2018
-$16.99 M(-38.4%)
-$3.80 M(+0.9%)
-$16.99 M(-17.2%)
Sep 2018
-
-$3.76 M(-11.9%)
-$20.51 M(-10.3%)
Jun 2018
-
-$4.27 M(-17.3%)
-$22.88 M(-13.1%)
Mar 2018
-
-$5.16 M(-29.5%)
-$26.32 M(-4.6%)
Dec 2017
-$27.59 M(-6.5%)
-$7.32 M(+19.4%)
-$27.59 M(+7.1%)
Sep 2017
-
-$6.13 M(-20.5%)
-$25.77 M(+1.6%)
Jun 2017
-
-$7.71 M(+19.9%)
-$25.36 M(+1.2%)
Mar 2017
-
-$6.43 M(+17.1%)
-$25.06 M(-15.6%)
Dec 2016
-$29.50 M(-42.8%)
-$5.49 M(-4.1%)
-$29.70 M(-4.3%)
Sep 2016
-
-$5.73 M(-22.7%)
-$31.04 M(-13.0%)
Jun 2016
-
-$7.41 M(-33.1%)
-$35.70 M(-19.9%)
Mar 2016
-
-$11.07 M(+62.0%)
-$44.56 M(-13.6%)
Dec 2015
-$51.58 M(-10.7%)
-$6.84 M(-34.2%)
-$51.58 M(-14.5%)
Sep 2015
-
-$10.38 M(-36.2%)
-$60.29 M(-8.9%)
Jun 2015
-
-$16.27 M(-10.1%)
-$66.17 M(+6.2%)
Mar 2015
-
-$18.09 M(+16.3%)
-$62.33 M(+7.9%)
Dec 2014
-$57.74 M(+56.9%)
-$15.55 M(-4.3%)
-$57.74 M(+9.6%)
Sep 2014
-
-$16.26 M(+30.8%)
-$52.68 M(+15.2%)
Jun 2014
-
-$12.43 M(-7.9%)
-$45.74 M(+10.3%)
Mar 2014
-
-$13.50 M(+28.6%)
-$41.48 M(+12.7%)
Dec 2013
-$36.81 M(+21.1%)
-$10.49 M(+12.7%)
-$36.81 M(+7.4%)
Sep 2013
-
-$9.31 M(+14.0%)
-$34.26 M(+3.7%)
Jun 2013
-
-$8.17 M(-7.5%)
-$33.03 M(+4.3%)
Mar 2013
-
-$8.83 M(+11.2%)
-$31.67 M(+4.2%)
Dec 2012
-$30.39 M(-10.6%)
-$7.94 M(-1.8%)
-$30.39 M(+1.3%)
Sep 2012
-
-$8.09 M(+18.8%)
-$30.00 M(+2.9%)
Jun 2012
-
-$6.81 M(-9.7%)
-$29.14 M(-10.0%)
Mar 2012
-
-$7.54 M(-0.2%)
-$32.37 M(+1.5%)
DateAnnualQuarterlyTTM
Dec 2011
-$34.00 M(+85.6%)
-$7.56 M(+4.5%)
-$31.90 M(+3.5%)
Sep 2011
-
-$7.23 M(-28.0%)
-$30.81 M(+5.1%)
Jun 2011
-
-$10.04 M(+41.9%)
-$29.32 M(+28.7%)
Mar 2011
-
-$7.08 M(+9.4%)
-$22.79 M(+24.4%)
Dec 2010
-$18.32 M(-29.2%)
-$6.47 M(+12.6%)
-$18.32 M(-23.6%)
Sep 2010
-
-$5.74 M(+64.0%)
-$23.98 M(-5.8%)
Jun 2010
-
-$3.50 M(+34.3%)
-$25.47 M(-4.5%)
Mar 2010
-
-$2.61 M(-78.5%)
-$26.66 M(+2.9%)
Dec 2009
-$25.87 M(+180.2%)
-$12.12 M(+67.7%)
-$25.91 M(+59.8%)
Sep 2009
-
-$7.23 M(+53.9%)
-$16.22 M(+48.7%)
Jun 2009
-
-$4.70 M(+153.1%)
-$10.91 M(+27.3%)
Mar 2009
-
-$1.86 M(-23.6%)
-$8.57 M(-7.2%)
Dec 2008
-$9.23 M(-11.5%)
-$2.43 M(+26.6%)
-$9.23 M(+1.0%)
Sep 2008
-
-$1.92 M(-18.7%)
-$9.14 M(-20.8%)
Jun 2008
-
-$2.36 M(-6.5%)
-$11.54 M(+3.6%)
Mar 2008
-
-$2.52 M(+7.9%)
-$11.14 M(+6.8%)
Dec 2007
-$10.44 M(+122.5%)
-$2.34 M(-45.9%)
-$10.44 M(+6.3%)
Sep 2007
-
-$4.32 M(+120.9%)
-$9.81 M(+51.2%)
Jun 2007
-
-$1.96 M(+7.6%)
-$6.49 M(+16.5%)
Mar 2007
-
-$1.82 M(+5.9%)
-$5.57 M(+18.8%)
Dec 2006
-$4.69 M(+193.0%)
-$1.72 M(+72.1%)
-$4.69 M(+35.4%)
Sep 2006
-
-$998.00 K(-3.8%)
-$3.46 M(+15.2%)
Jun 2006
-
-$1.04 M(+10.7%)
-$3.01 M(+29.3%)
Mar 2006
-
-$937.40 K(+91.1%)
-$2.33 M(+45.3%)
Dec 2005
-$1.60 M(+8.6%)
-$490.50 K(-9.5%)
-$1.60 M(+16.6%)
Sep 2005
-
-$542.10 K(+52.3%)
-$1.37 M(+10.0%)
Jun 2005
-
-$355.90 K(+67.6%)
-$1.25 M(-4.4%)
Mar 2005
-
-$212.40 K(-19.1%)
-$1.31 M(-11.4%)
Dec 2004
-$1.47 M(+64.9%)
-$262.60 K(-37.1%)
-$1.47 M(-6.8%)
Sep 2004
-
-$417.40 K(+1.0%)
-$1.58 M(+16.2%)
Jun 2004
-
-$413.30 K(+8.5%)
-$1.36 M(+18.1%)
Mar 2004
-
-$381.00 K(+3.1%)
-$1.15 M(+28.8%)
Dec 2003
-$894.30 K(-22.2%)
-$369.40 K(+87.7%)
-$894.40 K(+1.4%)
Sep 2003
-
-$196.80 K(-3.9%)
-$882.10 K(-3.1%)
Jun 2003
-
-$204.70 K(+65.7%)
-$910.30 K(+0.4%)
Mar 2003
-
-$123.50 K(-65.4%)
-$906.50 K(-21.1%)
Dec 2002
-$1.15 M(-28.4%)
-$357.10 K(+58.7%)
-$1.15 M(-7.4%)
Sep 2002
-
-$225.00 K(+12.0%)
-$1.24 M(-11.5%)
Jun 2002
-
-$200.90 K(-45.2%)
-$1.40 M(-9.8%)
Mar 2002
-
-$366.30 K(-18.5%)
-$1.55 M(-0.8%)
Dec 2001
-$1.61 M(-36.2%)
-$449.50 K(+16.6%)
-$1.57 M(-12.8%)
Sep 2001
-
-$385.60 K(+9.3%)
-$1.80 M(-26.4%)
Jun 2001
-
-$352.90 K(-6.7%)
-$2.44 M(-5.1%)
Mar 2001
-
-$378.20 K(-44.3%)
-$2.57 M(+4.4%)
Dec 2000
-$2.52 M(+146.1%)
-$679.40 K(-34.0%)
-$2.46 M(+38.1%)
Sep 2000
-
-$1.03 M(+113.1%)
-$1.78 M(+136.9%)
Jun 2000
-
-$483.10 K(+79.5%)
-$752.20 K(+179.5%)
Mar 2000
-
-$269.10 K
-$269.10 K
Dec 1999
-$1.02 M(+138.8%)
-
-
Dec 1998
-$428.20 K(+93.2%)
-
-
Mar 1998
-$221.60 K(-11.9%)
-
-
Mar 1997
-$251.60 K(-2.1%)
-
-
Mar 1996
-$257.10 K
-
-

FAQ

  • What is Lisata Therapeutics annual operating income?
  • What is the all time high annual operating profit for Lisata Therapeutics?
  • What is Lisata Therapeutics annual operating profit year-on-year change?
  • What is Lisata Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Lisata Therapeutics?
  • What is Lisata Therapeutics quarterly operating profit year-on-year change?
  • What is Lisata Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Lisata Therapeutics?
  • What is Lisata Therapeutics TTM operating profit year-on-year change?

What is Lisata Therapeutics annual operating income?

The current annual operating profit of LSTA is -$25.71 M

What is the all time high annual operating profit for Lisata Therapeutics?

Lisata Therapeutics all-time high annual operating income is -$221.60 K

What is Lisata Therapeutics annual operating profit year-on-year change?

Over the past year, LSTA annual operating income has changed by +$31.89 M (+55.37%)

What is Lisata Therapeutics quarterly operating income?

The current quarterly operating profit of LSTA is -$5.34 M

What is the all time high quarterly operating profit for Lisata Therapeutics?

Lisata Therapeutics all-time high quarterly operating income is -$123.50 K

What is Lisata Therapeutics quarterly operating profit year-on-year change?

Over the past year, LSTA quarterly operating income has changed by +$689.00 K (+11.44%)

What is Lisata Therapeutics TTM operating income?

The current TTM operating profit of LSTA is -$23.48 M

What is the all time high TTM operating profit for Lisata Therapeutics?

Lisata Therapeutics all-time high TTM operating income is -$269.10 K

What is Lisata Therapeutics TTM operating profit year-on-year change?

Over the past year, LSTA TTM operating income has changed by +$2.22 M (+8.65%)